NA was applied to the monolayer at an activity of 2~C i / ml in Krebs / Hepes buffer. After incubation the buffer was removed, the monolayer washed, and perchloric acid (0.4M) was added to extract the catecholamines taken up by the cells. Samples of these extracts were counted, and catecholamine uptake was expressed as a percentage of the total added radioactivity.
Results showed that B65 cells did not take up either DA or NA (<1 % at 60 min). In contrast, SH-SY5Y cells were capable of significant uptake of both DA and NA (>20 % at 60 min) (see table 1). Furthermore, unlike B65 cells, the uptake of DA and NA into SH-SY5Y cells was blocked by the catecholamine uptake inhibitor, imipramine. The small amount of DA and NA in B65 cells was not in a releasable pool since 1mM carbachol (CCH) did not stimulate release (basal 6.4 %, CCH 6.2 %). In contrast, SH-SYSY cells stored DA and NA in a releasable pool, with ImM CCH stimulating release from 2.7 f 0.2 (basal, n=6) to 7.2 f 1.0% (CCH, n=5, p<0.05) and 1.94 f 0.17 (basal, n=5) to 4.94 f 0.49% (CCH, n=5, p<0.05) for DA and NA respectively. However, DA is probably converted to NA by dopamine-phydoxylase prior to release.
This comparative study has demonstrated the inability of B65 cells to take up the catecholamines DA and NA, inconsistent with their high levels of tyrosine hydroxylase activity. Therefore, B65 cells appear an unsuitable model with which to study the effects of any potential neurotoxins which are taken up via catecholaminergic carriers in vivo in order to facilitate their toxicity.
Such neurotoxins may include the nicotinamide derivatives, N-methyl nicotinamide and 6-methyl nicotinamide 141, since they are reported to interact through dopaminergic systems in vivo [6] . Therefore, the probable lack of a catecholamine uptake system on B65 cells may help to explain the high concentrations required to induce N'-methyl nicotinamide and 6-methyl nicotinamide cytotoxicity reported previously 171.
